-
India next on Abbott’s global rebranding map
In a bid to reach out and engage with consumers more, the $22-billion US healthcare major Abbott is redefining its corporate identity, with India becoming one of the first markets after the US and Brazil where the change is being rolled out.
- Categories
- Health Care
- Region
- South Asia
-
India might get sick before it gets rich: Krishna Kumar
Interview with Vice-chairman and MD, Philips India
- Categories
- Health Care
- Region
- South Asia
-
India next on Abbott’s global rebranding map
In a bid to reach out and engage with consumers more, the $22-billion US healthcare major Abbott is redefining its corporate identity, with India becoming one of the first markets after the US and Brazil where the change is being rolled out.
- Categories
- Health Care
- Region
- South Asia
-
Indian start-up to enable bank transactions via kirana stores
Novopay uses Aadhaar biometric scanner for dealings
- Categories
- Uncategorized
- Region
- South Asia
-
USAID encourages private sector participation in new healthcare program
The U.S. Agency for International Development (USAID) on Friday launched its Healthy Markets program, an initiative to encourage the investment of local private sector and foster growth of a commercial market, in Ho Chi Minh City.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public health
-
Mumbai’s dream of becoming an international financial center may soon be a reality
Other centres in Asia may be losing their shine—Dubai is surrounded by geopolitical chaos and Singapore is apparently turning less attractive to expatriate workers due to slowing economic growth—marking an opportunity for Mumbai to aspire to that regional position.
- Categories
- Uncategorized
- Region
- South Asia
-
Indore: Approval for mobile app to curb dengue spread hangs fire
Even as dengue cases rise, government approval for a mobile app that could prevent the disease from spreading by speeding up monitoring and intervention is hanging fire.
- Categories
- Health Care, Technology
- Region
- South Asia
-
Eli Lilly shares MDR-TB drug technology with Shasun Pharma
US drug maker Eli Lilly and Company said on Thursday that it had shared the manufacturing technology for two antibiotic drugs meant for the treatment of multi-drug resistant tuberculosis (MDR-TB) with India’s Shasun Pharmaceuticals Ltd as part of its ongoing programme to increase access of these medicines in countries including India, China, Russia and South Africa, where drug-resistant TB is most prevalent.
- Categories
- Health Care
- Region
- South Asia
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.